PBE | Invesco Dynamic Biotechnology & Genome ETF Overview

(Stock Exchange: AMEX)

Day's Range	N/A - N/A
52 Week Range	N/A - N/A
Beta	0.77
Implied Volatility	13.00%
IV Rank	24.42%
Day's Volume	N/A
Average Volume	N/A
Shares Outstanding	N/A
Inception Date	2005-06-23

Assets	261,125,400
Asset Class	Equity
Expense Ratio	0.59
P/E Ratio	N/A
EPS	N/A
Dividend Yield	0.21%
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

*Chart delayed

Watching at PBE technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PBE Technicals page.